Home › NDC Lookup › RxCUI directory › RxCUI 197900

Lorazepam 0.5 MG Oral Tablet — RxCUI 197900

RxNorm drug concept · Semantic clinical drug
RxCUI 197900 Semantic clinical drug · SCD ● Current RxNorm concept 70 FDA products 264 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197900
Official nameLorazepam 0.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped70
Package NDCs mapped264
Reported Medicaid activity (SDUD)1,997,968 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lorazepam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lorazepam is mainly prescribed for anxiety disorders — it can calm anxious feelings and physical tension, especially for short periods. In tablet or liquid form, it's used for ongo...
  • Yes, drowsiness is one of the most common effects — and for many people that's actually part of how it helps with anxiety. You may also notice some unsteadiness, dizziness, or mild...
  • Will lorazepam make me feel really drowsy?
  • No — please avoid alcohol completely while you're on lorazepam. Both alcohol and lorazepam slow down your central nervous system, and together they can make that effect dangerously...
📖 Read our full Lorazepam guide →

🕸️ Concept Web — How Lorazepam 0.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lorazepam 0.5 MG Oral Tablet RxCUI 197900

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lorazepam 6470
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ativan 202479
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lorazepam Oral Tablet 372647
    • Lorazepam Oral Product 1165340
    • Lorazepam Pill 1165341
    • Lorazepam Oral Tablet [Ativan] 91879
    • Ativan Oral Product 1172874
    • Ativan Pill 1172875
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lorazepam 0.5 MG SCDC · 317407
  • Lorazepam Oral Tablet SCDF · 372647
  • Lorazepam Oral Product SCDG · 1165340
  • Lorazepam Pill SCDG · 1165341

Brand-Name Concepts

  • Lorazepam 0.5 MG Oral Tablet [Ativan] SBD · 206821
  • Lorazepam 0.5 MG [Ativan] SBDC · 567628
  • Lorazepam Oral Tablet [Ativan] SBDF · 91879
  • Ativan Oral Product SBDG · 1172874
  • Ativan Pill SBDG · 1172875
  • Ativan BN · 202479

📦 FDA Products & Package NDCs

70 products · 264 package NDCs
264 package NDCs map to RxCUI 197900 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76420-0872-90 90 TABLET in 1 BOTTLE (76420-872-90) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0873-00 1000 TABLET in 1 BOTTLE (76420-873-00) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0873-01 100 TABLET in 1 BOTTLE (76420-873-01) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0873-05 500 TABLET in 1 BOTTLE (76420-873-05) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0873-30 30 TABLET in 1 BOTTLE (76420-873-30) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0873-60 60 TABLET in 1 BOTTLE (76420-873-60) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0873-90 90 TABLET in 1 BOTTLE (76420-873-90) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0874-00 1000 TABLET in 1 BOTTLE (76420-874-00) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0874-01 100 TABLET in 1 BOTTLE (76420-874-01) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0874-05 500 TABLET in 1 BOTTLE (76420-874-05) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0874-30 30 TABLET in 1 BOTTLE (76420-874-30) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0874-60 60 TABLET in 1 BOTTLE (76420-874-60) Lorazepam Asclemed USA, Inc. 2024-11-06
76420-0874-90 90 TABLET in 1 BOTTLE (76420-874-90) Lorazepam Asclemed USA, Inc. 2024-11-06
87441-0050-01 30 TABLET in 1 BLISTER PACK (87441-050-01) Lorazepam Unit Dose Solutions, Inc. 2026-06-25
Observed labelers: Aphena Pharma Solutions - Tennessee, LLC (88) · Asclemed USA, Inc. (22) · Bryant Ranch Prepack (18) · Proficient Rx LP (16) · PD-Rx Pharmaceuticals, Inc. (14) · Aurolife Pharma LLC (12) · +21 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.